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Neuroﬁbromatosis-1 (NF1) is an autosomal dominant disease with an incidence of 1 in every 2500 to
3000 births [1]. Although neuroﬁbromas that result from the NF1 gene mutation are typically benign,
they may cause complications by compressing neighboring structures or undergoing malignant trans-
formation. The various manifestations and symptoms of NF1 may cause a number of complications
throughout childhood and into adulthood, and patients often require surgical management of these
complications. A young adult with a previous NF1 diagnosis presented with symptoms concerning for
appendicitis. Subsequent imaging and biopsy revealed a rare appendiceal neuroﬁbroma. The patient
underwent an ileocecectomy and pathology conﬁrmed the diagnosis of appendiceal neuroﬁbroma. The
variety of symptoms and complications associated with NF1, such as vascular abnormalities and airway
obstruction, create unique surgical risks for these patients. These risks should be understood and
accounted for by surgeons who may encounter NF1 patients.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Neuroﬁbromatosis-1, an autosomal dominant disease with an
incidence of 1 in 2500 to 1 in 3000 births, is typically characterized
by multiple benign cutaneous, subcutaneous, or plexiform neuro-
ﬁbromas [1]. NF1 patients are typically diagnosed during child-
hood, require multiple operations both as children and as adults,
and are followed by a child neurologist throughout their lives.
Complications associated with NF1 are often a result of the spatial
arrangement of neuroﬁbromas or result from other consequences
of the gene mutation, such as scoliosis; however, malignant trans-
formation of neuroﬁbromas may occur in some patients. Close
monitoring, clear imaging, and precise operative management are
important in the care of NF1 patients in order to reduce compli-
cations associated with both benign and malignant masses. Here,ouston, TX 77030-1439, USA.
tin).
Inc. This is an open access article uwe present a case of an NF1 patient with a rare appendiceal
neuroﬁbroma and consider the unique surgical risks associated
with NF1.
1. Case report
A twenty-four year old young man presented to an emergency
department with complaints of abdominal pain, nausea, and
vomiting suggestive of acute appendicitis. The patient’s medical
history was signiﬁcant for NF1 and hypertension secondary to left
renal artery stenosis. Hypertension was ﬁrst noted at three years of
age and subsequent CT angiogram revealed multiple anomalous
renal arteries, one of which was stenotic and required a stent
(Fig. 1). These vascular abnormalities, along with the presence of
café-au-lait macules and cutaneous ﬁbromas led to the diagnosis of
NF1 at seven years of age. He also suffers from developmental delay
and aggressive behavior, both of which may be attributed to NF1.
Upon physical examination in the emergency department,
multiple cutaneous ﬁbromas and café-au-lait macules (Fig. 2), as
well as tenderness to palpation in the right lower quadrant of the
abdomen, were noted. The patient was afebrile. Based on CTnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 3. (A and B) MRI with contrast of the abdomen and pelvis demonstrating a T2
hyperintense elongated appendiceal mass (top) and CT with contrast of the abdomen
and pelvis demonstrating a mass-like enlargement of the appendix (bottom).
Fig. 1. CT angiogram. Note multiple anomalous renal arteries and a stent placed in a
left renal artery.
A. Wilson et al. / J Ped Surg Case Reports 3 (2015) 492e495 493ﬁndings, the patient was diagnosed with appendicitis and
possible mesenteric panniculitis and he was started on
intravenous cefotetan. He was discharged ﬁve days later after
symptoms resolved. Further review of CT ﬁndings raised
concern of an associated appendiceal mass, and follow-up
imaging demonstrated a mid-appendiceal mass of 2.5 cm  7 cm
(Fig. 3A and B).
An endoscopic biopsy was performed and revealed a positive
S100 immunostain consistent with appendiceal neuroﬁbroma
(Fig. 4).
The patient then underwent a hand-assisted laparoscopic ileo-
cecectomy. There were no perioperative complications and the
patient was discharged the following day.
Pathological assessment revealed a 8.0 cm circumferential
intramural appendiceal mass located within 3.5 cm of the cecal
margin (Fig. 5). Histological sectioning demonstrated a plexiformFig. 2. Café-au-lait macules.neuroﬁbroma extending from the mucosa to the muscularis
propria (Fig. 6A). There was no nuclear atypia or signs of pro-
gression to a malignant peripheral nerve sheath tumor. S100 and
neuroﬁlament immunostains were positive, conﬁrming the diag-
nosis of appendiceal neuroﬁbroma (Fig. 6B). CD117 was negative,
excluding gastrointestinal stromal tumor (GIST) as a possible
diagnosis.2. Discussion
Neuroﬁbromatosis-1 is estimated to effect 1 in every
2500e3000 births [1]. NF1 occurs as the result of an autosomal
dominant mutation in the NF1 tumor suppressor gene [2]. Clinical
diagnostic criteria for NF1 have been established (Table 1), but
genetic testing is necessary in patients who are not easily diagnosed
by clinical criteria or who were previously diagnosed with NF1 and
wish to participate in family planning counseling.
Although neuroﬁbromas are typically benign, children and
adults with NF1 are at risk for malignant transformation.
Neuroﬁbromatosis-1 (NF1) patients have a lifetime risk of ma-
lignancy 3% greater than the general population [4]. Speciﬁcally,
adult and pediatric patients are at risk of glioma and malignant
schwannoma, and children with NF1 are at an increased risk for
mylogenous leukemia and rhabdomyosarcoma [5]. Tumors such
as carcinoid and malignant peripheral nerve sheath tumors also
arise at an increased frequency in NF1 patients and often have a
poor prognosis [4]. More common benign neuroﬁbromas can also
cause a variety of complications. NF1 patients are at risk for optic
pathway gliomas, neural tumors, gastrointestinal tumors, vascular
abnormalities such as renal stenosis and anomalous vessels,
orthopedic issues such as scoliosis, and cosmetically
disﬁguring lesions [6]. Thus, NF1 patients often require surgical
resection of their tumors, including both benign and malignant
lesions.
Fig. 4. Endoscopy images. Shown are (A) the mass in the appendix and the appendiceal os, (B) the proapsing appendiceal mass, (C) the base of the appendix and (D) the inﬁltrated
mucosa of the cecum.
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10e25% experience gastrointestinal manifestations [7e9]. These
masses can cause complications such as obstruction, gastrointes-
tinal bleeding, and perforation; however, only 5% of the gastroin-
testinal masses that arise in NF1 patients are symptomatic [9,10].
Gastrointestinal tumors associated with NF1 typically arise mid to
late in life and are rarely found in the appendix [9,10]. To date,
there have been only four previous case reports of appendiceal
neuroﬁbroma in the English literature [11e14]. Table 2 summarizesFig. 5. The gross mass, appendix and a portion of the cecum.the cases of appendiceal neuroﬁbromas in the literature to date. In
four of the ﬁve patients, the appendiceal mass was found
following complaints of abdominal pain. One patient was asymp-
tomatic and the mass was found during a cesarean section [13].
Three patients underwent appendectomy exclusively; one patient
had a right hemicolectomy and appendectomy and our patient
underwent ileocecectomy.
The primary treatment for symptomatic neuroﬁbromatosis,
including both benign and malignant lesions, is complete surgical
excision. NF1 patients present with a unique set of surgical risk
factors, and surgeons should take special care in anticipating and
reducing these risks. Airway control can be difﬁcult for NF1 pa-
tients under anesthesia due to the presence of neuroﬁbromas in
the oropharynx or surrounding soft tissue [15]. In a study
addressing the utility of routine head and neck screening of pe-
diatric NF1 patients, the clinical management of 9% of patients
was altered due to the presence of cervical masses [16]. Compli-
cations related to hypertension should also be monitored, as the
condition is present in many pediatric NF1 patients and in nearly
20% of NF1 patients over the age of 60 and is commonly a sec-
ondary consequence of conditions such as renal artery stenosis,
coarctation of the aorta, and pheochromocytoma [8,17]. Arterial
aneurysms and hemorrhage are frequently observed in this
population, so it may be prudent for surgeons to consider safe-
guards such as routine preoperative angiography, preoperative
embolization, and hypotensive anesthesia [8]. Neuroﬁbromas of
the thoracic cavity may compromise the phrenic, vagus, spinal, or
intercostal nerves leading to complications such as diaphragm
paralysis [8]. Finally, surgeons should understand the risk of
malignancy in NF1 patients. Appropriate imaging should be
Fig. 6. (A and B) Appendix wall with mucosal and submucosal involvement by plex-
iform neuroﬁbromatosis. Hematoxylin and eosin stain; 100 (top). S100 immunostain
highlights the neuroﬁbromatosis involving the deep muscularis propria of the ap-
pendix. Immunohistochemical stain for S100; 100 (bottom).
Table 2
Appendiceal neuroﬁbromatosis cases in the literature.
Year
(reference
number)
Age/
gender
Symptom Tumor
size (cm)
Operative
management
Other NF1
manife
stations
Family
history
of
NF1
1975 [11] 24/M Abdominal
pain
Un
known
Appendectomy Skin
lesions
No
1987 [12] 24/M Abdominal
pain
7  3 Appendectomy None No
2006 [13] 33/F Asymptomatic 12 Appendectomy Skin
lesions
No
2014 [14] 62/F Abdominal
pain
9  7 Right
hemicolectomy
Skin
lesions
No
2015 24/M Abdominal
pain
2.5  7 Ileocecectomy Skin
lesions
No
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with NF1 and to select the best surgical intervention for the
patient.3. Conclusion
Appendiceal neuroﬁbromas are rare, late onset, benign mani-
festations of NF1. NF1 patients should be closely monitored forTable 1
Clinical diagnostic criteria for neuroﬁbromatosis-1 (NF1) [3].
Patients have two or more of the following symptoms:
 6 or more café-au-lait macules (>0.5 cm in children of >1.5 cm in adults)
 2 or more cutaneous or subcutaneous neuroﬁbromas or one plexiform
neuroﬁbroma
 Axillary or groin freckling
 Optic glioma
 2 or more Lisch nodules (iris hamartomas visualized on slit lamp
examination)
 Sphenoid wing dysplasia or bowing of long bone
(with or without pseudarthrosis)
 First degree relative with an NF1 diagnosisthese gastrointestinal neuroﬁbromas, as they may cause discom-
fort and have the capacity for malignant transformation or other
serious complications. Surgery is often the only treatment option
for NF1 patients with neuroﬁbromas of the gastrointestinal
system or elsewhere, so surgeons should be cautious of
the unique set of surgical risks associated with neuroﬁbroma-
tosis-1.
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